COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1787: Articles 17861-17870  | Next

At the Intersection Between SARS-CoV-2, Macrophages and the Adaptive Immune Response: A Key Role for Antibody-Dependent Pathogenesis But Not Enhancement of Infection in COVID-19
DeMarco, J. K., Severson, W., DeMarco, D., Pogue, G., Gabbard, J. D., Palmer, K. E.
10.1101/2021.02.22.432407 — Posted: 2021-02-23
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.
Ma, L., Sahu, S. K., Cano, M., Kuppuswamy, V., Bajwa, J., McPhatter, J., Pine, A. B., Meizlish, M. M., Goshua, G., Chang, C. H., Zhang, H., Price, C., Bahel, P., Rinder, H. M., Lei, T., Day, A., Reynolds, D., Wu, X., Schriefer, R., Rauseo, A. M., Goss, C. W., O'Halloran, J. A., Presti, R. M., Kim, A. H., Gelman, A. E., Dela Cruz, C. S., Lee, A. I., Mudd, P. A., Chun, H. J., Atkinson, J. P., Kulkarni, H. S.
10.1101/2021.02.22.432177 — Posted: 2021-02-23
SARS-CoV-2 causes brain inflammation and induces Lewy body formation in macaques
Philippens, I. H. C. H. M., Boszormenyi, K. P., Wubben, J. A., Fagrouch, Z. C., van Driel, N., Mayenburg, A. Q., Lozovagia, D., Roos, E., Schurink, B., Bugiani, M., Bontrop, R. E., Middeldorp, J., Bogers, W. M., de Geus-Oei, L.-F., Langermans, J. A. M., Stammes, M. A., Verstrepen, B. E., Verschoor, E. J.
10.1101/2021.02.23.432474 — Posted: 2021-02-23 Discussion: Onsite
A rapid review of equity considerations in large-scale testing campaigns during infectious disease epidemics
Ost, K., Duquesne, L., Duguay, C., Traverson, L., Mathevet, I., Ridde, V., Zinszer, K.
10.1101/2021.02.22.21252205 — Posted: 2021-02-23
Estimating the spreading and dominance of SARS-CoV-2 VOC 202012/01 (lineage B.1.1.7) across Europe
Gozzi, N., Chinazzi, M., Davis, J. T., Mu, K., Pastore y Piontti, A., Ajelli, M., Perra, N., Vespignani, A.
10.1101/2021.02.22.21252235 — Posted: 2021-02-23
Factors Associated with Timely Test Seeking, Test Turnaround, and Public Reporting of COVID-19: a retrospective analysis in Ontario, Canada
Joh, E., Buchan, S. A., Daneman, N., Paul, L. A., Brown, K. A.
10.1101/2021.02.22.21252219 — Posted: 2021-02-23
Vaccination efforts in Brazil: scenarios and perspectives under a mathematical modeling approach
Nogueira Vilches, T., Rubio, F. A., Forti Perroni, R., Berg de Almeida, G., Pio Ferreira, C., Fortaleza, C. M. C. B.
10.1101/2021.02.22.21252208 — Posted: 2021-02-23
Impact of environmental temperature on Covid-19 spread: Model and analysis of measurements recorded during the second pandemic in Cyprus
Livadiotis, G.
10.1101/2021.02.19.21252106 — Posted: 2021-02-23
An efficient benchmark for COVID-19 pandemic testing effectiveness
Nikoloudis, D., Kountouras, D., Hiona, A.
10.1101/2021.02.20.21252138 — Posted: 2021-02-23
Modelling the Impact of Delaying Vaccination Against SARS-CoV-2 Assuming Unlimited Vaccines Supply
Massad, E., Amaku, M., Covas, D. T., de azevedo Neto, R. S., Coutinho, F. A. B.
10.1101/2021.02.22.21252189 — Posted: 2021-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).